Maravai Lifesciences Holdings reported cash from operations of $3.99M and free cash flow of $3.62M for the quarter ended Jun 2026, up 138.9% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | 132.18M | 127.11M | 146.86M | 156.72M | 99.65M | 87.43M | -1.35M | -11.94M | -15.10M | -109.98M | -22.68M | -18.42M | -172.46M | -46.07M | -52.85M | -69.84M | -45.06M | -63.02M | -6.38M | -21.63M | ||||||
| Share-based CompensationStock Comp. | 3.57M | 2.23M | 3.63M | 7.10M | 6.00M | 5.99M | 9.34M | 12.06M | 13.76M | 13.05M | 10.54M | 10.40M | 6.79M | 9.06M | 3.93M | 6.74M | 10.21M | |||||||||
| Deferred Taxes | 11.23M | 17.47M | 13.22M | 12.86M | 9.23M | 7.01M | -1.52M | -2.76M | -5.53M | 764.75M | 0.01M | |||||||||||||||
| Gains from Investment SecuritiesGains Investment | -7.80M | -7.80M | -5.29M | -2.32M | 2.38M | -3.35M | -1.20M | -0.18M | -0.63M | 0.14M | ||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 12.44M | 31.50M | 4.90M | 0.60M | -0.14M | |||||||||||||||||||||
| Cash from OperationsCash from Ops. | 105.56M | 58.74M | 162.30M | 164.28M | 110.06M | 99.33M | 85.07M | 19.19M | 14.17M | 7.79M | -8.47M | 17.43M | 13.14M | -14.64M | -9.39M | -10.27M | -15.15M | -22.77M | 8.66M | 3.99M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 1.60M | 3.68M | 1.87M | 0.77M | 1.80M | 1.83M | 2.06M | 2.13M | 2.15M | 2.18M | 2.10M | 2.12M | 2.10M | 2.16M | 2.19M | 2.23M | 2.26M | 2.29M | 1.61M | 1.62M | ||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.68M | 0.68M | 0.70M | 0.71M | 0.72M | 0.65M | 0.72M | 0.73M | 0.74M | 0.74M | 0.74M | 0.74M | 0.75M | 0.66M | 0.46M | 0.39M | 0.40M | 0.40M | ||||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -17.62M | 51.54M | 2.22M | 0.12M | -5.83M | 25.77M | -82.41M | -7.56M | -3.21M | 8.79M | -17.88M | -1.89M | -6.02M | 11.43M | -10.16M | -0.50M | -5.12M | 2.96M | 7.91M | -2.29M | ||||||
| Change in InventoryChange Inventory | 8.56M | -5.48M | -1.20M | 8.70M | 2.31M | -19.27M | 3.38M | -7.71M | 1.50M | 2.18M | -0.82M | -0.70M | 1.60M | -0.45M | -0.45M | -3.11M | -1.35M | -3.09M | -0.03M | 0.77M | ||||||
| Change in Account PayablesChange Payables | -2.62M | -0.87M | 1.95M | 4.36M | -4.42M | -3.47M | -0.23M | 1.87M | 1.99M | 1.66M | -3.68M | 4.57M | -2.42M | 2.25M | -0.71M | 1.78M | -2.91M | -5.51M | 6.16M | -1.80M | ||||||
| Change in Accured ExpensesChange Accured Exp. | 1.62M | 7.47M | -4.06M | 2.29M | 15.89M | -5.61M | 24.23M | -17.64M | 2.38M | 6.40M | -24.12M | 3.00M | -1.06M | -1.56M | 1.84M | 4.80M | 2.25M | -13.51M | -5.34M | 1.81M | ||||||
| Other Working Capital ChangesOther WC Changes | -42.78M | -56.51M | -6.52M | 1.74M | 0.39M | -2.73M | -1.06M | 0.41M | 0.09M | 0.81M | -1.15M | -0.06M | -0.24M | 0.47M | 0.38M | -1.12M | ||||||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital ExpendituresCapex | 1.33M | 5.66M | 2.75M | 1.66M | 6.47M | 6.21M | 7.87M | 25.06M | 15.83M | 16.80M | 5.67M | 9.55M | 8.59M | 5.85M | 4.50M | 2.87M | 3.66M | 2.11M | 4.44M | 0.37M | ||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | ||||||||||||||||||||||||||
| Acquisitions | 238.84M | 0.13M | 69.73M | -0.11M | 18.63M | 0.36M | ||||||||||||||||||||
| Divestments | 120.70M | |||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 118.63M | -5.66M | -241.58M | -1.66M | -5.85M | -18.52M | -69.73M | -24.16M | -15.52M | -12.90M | -4.24M | -6.18M | -8.96M | -4.93M | -23.13M | -3.24M | -2.93M | -2.11M | -4.44M | -0.37M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.31M | -1.33M | 1.26M | 0.73M | -1.99M | 0.49M | 1.40M | 1.96M | 2.32M | 2.38M | 2.34M | 2.35M | 2.23M | -3.54M | 4.54M | 0.37M | -7.02M | -3.87M | 3.41M | |||||||
| Cash from Financing ActivitiesCash from Financing | -51.28M | -49.58M | -40.52M | -43.41M | -37.44M | -66.12M | -19.21M | -43.13M | 0.78M | 0.47M | -0.56M | 0.23M | 0.81M | -236.19M | -4.90M | -1.53M | -8.25M | -1.82M | -55.23M | -98.98M | ||||||
| Dividend Payments | ||||||||||||||||||||||||||
| Dividends Paid - CommonDiv. Paid (Common) | 50.09M | 110.00M | 39.89M | 42.59M | 36.81M | 30.92M | 8.30M | 1.30M | 0.57M | -0.08M | ||||||||||||||||
| Additional items | ||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | 0.03M | -0.13M | 0.07M | -0.11M | -0.01M | 0.01M | 0.03M | 0.02M | ||||||||||||||||||
| Change in Cash | 172.94M | 3.37M | -119.80M | 119.21M | 66.77M | 14.69M | -3.87M | -48.10M | -0.57M | -4.64M | -13.27M | 11.48M | 4.99M | -255.76M | -37.35M | -15.15M | -26.33M | -26.68M | -50.97M | -95.34M | ||||||
| Free Cash FlowFCF | 104.23M | 53.09M | 159.56M | 162.62M | 103.59M | 93.12M | 77.21M | -5.87M | -1.66M | -9.01M | -14.13M | 7.88M | 4.54M | -20.49M | -13.89M | -13.14M | -18.81M | -24.88M | 4.23M | 3.62M | ||||||
| Net Cash FlowNCF | 172.91M | 3.51M | -119.80M | 119.21M | 66.77M | 14.69M | -3.87M | -48.10M | -0.57M | -4.64M | -13.27M | 11.48M | 4.99M | -255.76M | -37.42M | -15.04M | -26.32M | -26.70M | -51.00M | -95.36M |